Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE

https://doi.org/10.20996/1819-6446-2010-6-3-339-344

Full Text:

Abstract

Aim. To study antihypertensive efficacy and safety of amlodipine maleate as well as its influence on respiratory function, C reactive protein plasma level, glucose and lipid metabolism in patients with arterial hypertension (HT) and chronic obstructive pulmonary disease (COPD).

Material and methods. 50 patients with HT 1-3 grade and COPD I-II stage in remission were randomized into two groups. 31 patients of the first group were treated with amlodipine maleate (Stamlo-M) 5-10 mg/d alone or in combination. 19 patients of the second group received any other antihypertensive therapy except dihydropyridine calcium antagonists.

Results. Amlodipine in combined therapy has high antihypertensive efficacy providing achievement of target blood pressure levels and improvement of 24-hour blood pressure profile. Amlodipine therapy improved respiratory function and reduced systolic blood pressure in pulmonary artery. Amlodipine has no negative influence on metabolic status, did not increase sympathetic activity, and reduced C reactive protein levels. It demonstrated good tolerability and safety.

Conclusion. High antihypertensive efficacy, improvement of respiratory function, and safety allows recommending amlodipine maleate (Stamlo-M) for usage in hypertensive patients with COPD.

About the Authors

D. A. Yakhontov
Novosibirsk state medical university
Russian Federation
Krasnyy prosp 52, Novosibirsk, 630091


N. F. Balabanova
Novosibirsk state medical university
Russian Federation
Krasnyy prosp 52, Novosibirsk, 630091


References

1. Whelton P.K. Epidemiology of hypertension. Lancet 1994;344(9815):101-6.

2. Оганов Р.Г., Кухарчук В.В., БритовА.Н., редакторы. Борьба с артериальной гипертонией. Доклад Комитета экспертов ВОЗ. Пер. с англ. М; 1997.

3. Mancia G., De Backer G., Dominiczak A. et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25(6):1105-87.

4. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал 2006;(4):45-50.

5. Чазова И.Е., Ратова Л.Г., от имени исследователей "Клип-Аккорд". КЛИП-АККОРД: 4 года и 7796 пациентов — возможности полнодозовой комбинированной терапии артериальной гипертонии. Системные гипертензии 2008;(1):4-9.

6. ЧучалинА.Г., редактор. Хронические обструктивные болезни легких. М.: БИНОМ; 2000.

7. Мациевич М.В., Федорова И.В., Адашева Т.В. и др. Применение эпросартана у пациентов с артериальной гипертензией в сочетании с ХОБЛ. Клиническая фармакология и терапия 2007;(4):32-5.


For citation:


Yakhontov D.A., Balabanova N.F. EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Rational Pharmacotherapy in Cardiology. 2010;6(3):339-344. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-3-339-344

Views: 329


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)